The Instrument Shop Facility provides the Fox Chase Cancer Center's clinical and scientific research staff with consulting services on design, material and fabricating support for their research projects which require improvisation in the development of new equipment and the adaptation of specialized commercial equipment. The reviewers rated the Instrument Shop Facility at the previous site visit as """"""""Outstanding."""""""" The Facility manufactures equipment that cannot be procured from commercial sources. The Facility also modifies existing equipment to perform a specific function that might not have been possible, but is required by the scientist or clinical researcher. The Facility produces this equipment for the investigators with a turnaround time of a week or less, although specialized equipment may take up to a month or longer to complete. Forty-three (43) peer-reviewed, funded investigators from 9 of the Center's 11 research Programs utilized the mechanical expertise, support and consulting service of this Facility in calendar year 2003. This Facility, established in 1952, has operated under the direction of John W. Moeller, Sr. since 1989. The Facility has designed, developed, altered, and repaired 300 pieces of specialized equipment required by the scientific staff in 2003. Over the past five years the Facility has provided service to all of the Center's research Programs. In the next five years we expect the demand for consulting services and fabricating support on sophisticated one-of-a-kind equipment to increase. This expectation is based upon our reputation for providing excellent consulting and quality fabrication service and the Center's plans to recruit more investigators. Examples of equipment fabricated by this Facility for the Basic Science, Medical Science, and Population Science Divisions are listed below: 1. Robot Base Holders for Yeung (Biomolecular Structure and Function, Basic Science) 2. Hybridization Chamber Tops for Testa (Program Leader, Human Genetics, Population Science) 3. Incubation Chamber on Microscope for J. Russo (Breast Cancer, Medical Science) 4. Modification of Microscope Table for Bosma (Immunobiology, Basic Science)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA006927-47
Application #
7881779
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
47
Fiscal Year
2009
Total Cost
$205,387
Indirect Cost
Name
Fox Chase Cancer Center
Department
Type
DUNS #
073724262
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Fareed, Muhammad M; Eldib, Ahmed; Weiss, Stephanie E et al. (2018) A treatment planning comparison between a novel rotating gamma system and robotic linear accelerator based intracranial stereotactic radiosurgery/radiotherapy. Phys Med Biol 63:035029
Bleicher, Richard J (2018) Timing and Delays in Breast Cancer Evaluation and Treatment. Ann Surg Oncol 25:2829-2838
Mehrazin, Reza; Dulaimi, Essel; Uzzo, Robert G et al. (2018) The correlation between gain of chromosome 8q and survival in patients with clear and papillary renal cell carcinoma. Ther Adv Urol 10:3-10
Bai, Tian; Chanda, Ashis Kumar; Egleston, Brian L et al. (2018) EHR phenotyping via jointly embedding medical concepts and words into a unified vector space. BMC Med Inform Decis Mak 18:123
Tang, Baiqing; Lee, Hyung-Ok; An, Serim S et al. (2018) Specific Targeting of MTAP-Deleted Tumors with a Combination of 2'-Fluoroadenine and 5'-Methylthioadenosine. Cancer Res 78:4386-4395
Fang, Carolyn Y; Tseng, Marilyn (2018) Ethnic density and cancer: A review of the evidence. Cancer 124:1877-1903
Malik, R; Luong, T; Cao, X et al. (2018) Rigidity controls human desmoplastic matrix anisotropy to enable pancreatic cancer cell spread via extracellular signal-regulated kinase 2. Matrix Biol :
Giri, Veda N; Obeid, Elias; Hegarty, Sarah E et al. (2018) Understanding of multigene test results among males undergoing germline testing for inherited prostate cancer: Implications for genetic counseling. Prostate 78:879-888
Anari, Fern; O'Neill, John; Choi, Woonyoung et al. (2018) Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-invasive Bladder Cancer: Results of a Phase 2 Trial. Eur Urol Oncol 1:54-60
Drilon, Alexander; Laetsch, Theodore W; Kummar, Shivaani et al. (2018) Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children. N Engl J Med 378:731-739

Showing the most recent 10 out of 1280 publications